A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy

• Marcelo J. Wolff ,

  * E-mail: marcewolff@yahoo.com

  Affiliation Fundación Arriarán, Facultad de Medicina, Universidad de Chile, Santiago, Chile

  ⨯
• Mark J. Giganti,

  Affiliation Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, United States of America

  ⨯
• Claudia P. Cortes,

  Affiliation Fundación Arriarán, Facultad de Medicina, Universidad de Chile, Santiago, Chile

  ⨯
• Pedro Cahn,

  Affiliation Fundación Huésped, Buenos Aires, Argentina

  ⨯
• Beatriz Grinsztejn,

  Affiliation Instituto Nacional de Infectologia Evandro Chagas Fiocruz, Rio de Janeiro, Brazil

  ⨯
• Jean W. Pape,

  Affiliation Le Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti

  ⨯
• Denis Padgett,

  Affiliation Instituto Hondureño de Seguridad Social Hospital de Especialidades, Tegucigalpa, Honduras

  ⨯
• Juan Sierra-Madero,

  Affiliation Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Talplan, Mexico

  ⨯
• Eduardo Gotuzzo,

  Affiliation Universidad Peruana Cayetano Heredia, Hospital Nacional Cayetano Heredia, Lima, Perú

  ⨯
• Stephany N. Duda,

  Affiliation Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, United States of America

  ⨯
• Catherine C. McGowan,

  Affiliation Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America

  ⨯
• Bryan E. Shepherd,

  Affiliation Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, United States of America

  ⨯
• for the Caribbean, Central and South America Network for HIV Epidemiology

  ¶Membership of the Caribbean, Central and South America Network for HIV Epidemiology is provided in the Acknowledgments.

  ⨯